Introduction on Coronavirus Disease (COVID-19) Pandemic: The Global Challenge.

COVID-19 Humans Medicine Middle East Respiratory Syndrome Coronavirus Pandemics SARS-CoV-2
Borderless COVID-19 Coronavirus Global Immune system Pandemic SARS-CoV-2

Journal

Advances in experimental medicine and biology
ISSN: 0065-2598
Titre abrégé: Adv Exp Med Biol
Pays: United States
ID NLM: 0121103

Informations de publication

Date de publication:
2021
Historique:
entrez: 11 5 2021
pubmed: 12 5 2021
medline: 13 5 2021
Statut: ppublish

Résumé

By driving the ongoing pandemic of coronavirus disease 2019 (COVID-19), coronaviruses have become a significant change in twenty-first-century medicine, healthcare systems, education, and the global economy. This chapter rapidly reviews the origin, immunopathogenesis, epidemiology, diagnosis, clinical manifestations, and potential therapeutics of COVID-19. It would also explore the effects of the introduction of a single virus, the so-called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), on the public health preparedness planning.

Identifiants

DOI: 10.1007/978-3-030-63761-3_1 PMID: 33973169
pubmed: 33973169
doi: 10.1007/978-3-030-63761-3_1
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-22

Références

Abdullah AS, Tomlinson B, Cockram CS, Thomas GN (2003) Lessons from the severe acute respiratory syndrome outbreak in Hong Kong. Emerg Infect Dis 9(9):1042
pubmed: 14519237 pmcid: 3016765
Açikgöz Ö, Günay A (2020) The early impact of the Covid-19 pandemic on the global and Turkish economy. Turk J Med Sci 50(SI-1):520–526. https://doi.org/10.3906/sag-2004-6
doi: 10.3906/sag-2004-6 pubmed: 32283904 pmcid: 7195973
Ahmadi M, Saffarzadeh N, Habibi MA, Hajiesmaeili F, Rezaei N (2020, Jann 1) Colon cancer and SARS-CoV-2: impact of ACE2 expression in susceptibility to COVID-19. bioRxiv
Ahmed W, Angel N, Edson J, Bibby K, Bivins A, O’Brien JW, Choi PM, Kitajima M, Simpson SL, Li J (2020) First confirmed detection of SARS-CoV-2 in untreated wastewater in Australia: a proof of concept for the wastewater surveillance of COVID-19 in the community. Sci Total Environ 728:138764
pubmed: 32387778 pmcid: 7165106
Anyane-Yeboa A, Sato T, Sakuraba A (2020) Racial disparities in COVID-19 deaths reveal harsh truths about structural inequality in america. J Intern Med 288:479. https://doi.org/10.1111/joim.13117
doi: 10.1111/joim.13117 pubmed: 32452046
Ather A, Patel B, Ruparel NB, Diogenes A, Hargreaves KM (2020) Coronavirus disease 19 (COVID-19): implications for clinical dental care. J Endod 46(5):584–595. https://doi.org/10.1016/j.joen.2020.03.008
doi: 10.1016/j.joen.2020.03.008 pubmed: 32273156 pmcid: 7270628
Babaha F, Rezaei N (2020) Primary immunodeficiency diseases in COVID-19 pandemic: a predisposing or protective factor? Am J Med Sci. https://doi.org/10.1016/j.amjms.2020.07.027
Bahrami A, Vafapour M, Moazzami B, Rezaei N (2020, Jul 8) Hyperinflammatory shock related to COVID‐19 in a patient presenting with multisystem inflammatory syndrome in children: first case from Iran. J Paediatr Child Health
Banerjee D (2020) ‘Age and ageism in COVID-19’: elderly mental health-care vulnerabilities and needs. Asian J Psychiatr 51:102154. https://doi.org/10.1016/j.ajp.2020.102154
doi: 10.1016/j.ajp.2020.102154 pubmed: 32403024 pmcid: 7198430
Basiri A, Heidari A, Nadi MF, Fallahy MTP, Nezamabadi SS, Sedighi M, Saghazadeh A, Rezaei N (2020a) Microfluidic devices for detection of RNA viruses. Rev Med Virol n/a (n/a):e2154. https://doi.org/10.1002/rmv.2154
Basiri A, Pazhouhnia Z, Beheshtizadeh N, Hoseinpour M, Saghazadeh A, Rezaei N (2020b, Jun 20) Regenerative medicine in COVID-19 treatment: real opportunities and range of promises. Stem Cell Rev Rep 20:1–13
Bi Q, Wu Y, Mei S, Ye C, Zou X, Zhang Z, Liu X, Wei L, Truelove SA, Zhang T, Gao W, Cheng C, Tang X, Wu X, Wu Y, Sun B, Huang S, Sun Y, Zhang J, Ma T, Lessler J, Feng T (2020) Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study. Lancet Infect Dis 20:911. https://doi.org/10.1016/S1473-3099(20)30287-5
doi: 10.1016/S1473-3099(20)30287-5 pubmed: 32353347 pmcid: 7185944
Brooks SK, Webster RK, Smith LE, Woodland L, Wessely S, Greenberg N, Rubin GJ (2020) The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet 395:912
pubmed: 32112714 pmcid: 7158942
Bulut C, Kato Y (2020) Epidemiology of COVID-19. Turk J Med Sci 50(SI-1):563–570. https://doi.org/10.3906/sag-2004-172
doi: 10.3906/sag-2004-172 pubmed: 32299206 pmcid: 7195982
Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, Ruan L, Song B, Cai Y, Wei M, Li X, Xia J, Chen N, Xiang J, Yu T, Bai T, Xie X, Zhang L, Li C, Yuan Y, Chen H, Li H, Huang H, Tu S, Gong F, Liu Y, Wei Y, Dong C, Zhou F, Gu X, Xu J, Liu Z, Zhang Y, Li H, Shang L, Wang K, Li K, Zhou X, Dong X, Qu Z, Lu S, Hu X, Ruan S, Luo S, Wu J, Peng L, Cheng F, Pan L, Zou J, Jia C, Wang J, Liu X, Wang S, Wu X, Ge Q, He J, Zhan H, Qiu F, Guo L, Huang C, Jaki T, Hayden FG, Horby PW, Zhang D, Wang C (2020) A trial of lopinavir–ritonavir in adults hospitalized with severe Covid-19. N Engl J Med 382(19):1787–1799. https://doi.org/10.1056/NEJMoa2001282
doi: 10.1056/NEJMoa2001282 pubmed: 32187464
Cheema M, Aghazadeh H, Nazarali S, Ting A, Hodges J, McFarlane A, Kanji JN, Zelyas N, Damji KF, Solarte C (2020) Keratoconjunctivitis as the initial medical presentation of the novel coronavirus disease 2019 (COVID-19). Can J Ophthalmol 55:e125. https://doi.org/10.1016/j.jcjo.2020.03.003
doi: 10.1016/j.jcjo.2020.03.003 pubmed: 32284146 pmcid: 7124283
Chen L, Xiong J, Bao L, Shi Y (2020) Convalescent plasma as a potential therapy for COVID-19. Lancet Infect Dis 20(4):398–400. https://doi.org/10.1016/S1473-3099(20)30141-9
doi: 10.1016/S1473-3099(20)30141-9 pubmed: 32113510 pmcid: 7128218
Cherry JD (2004) The chronology of the 2002–2003 SARS mini pandemic. Paediatr Respir Rev 5(4):262–269
pubmed: 15531249 pmcid: 7106085
Chow KYC, Hon CC, Hui RKH, Wong RTY, Yip CW, Zeng F, Leung FCC (2003) Molecular advances in severe acute respiratory syndrome-associated coronavirus (SARS-CoV). Genomics Proteomics Bioinformatics 1(4):247–262
pubmed: 15629054 pmcid: 5172416
Clem AS (2011) Fundamentals of vaccine immunology. J Global Infect Dis 3(1):73–78. https://doi.org/10.4103/0974-777X.77299
doi: 10.4103/0974-777X.77299
Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DKW, Bleicker T, Brünink S, Schneider J, Schmidt ML (2020) Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Eurosurveillance 25(3):2000045
pmcid: 6988269
Cowling BJ, Leung GM (2020) Epidemiological research priorities for public health control of the ongoing global novel coronavirus (2019-nCoV) outbreak. Eurosurveillance 25(6):2000110
pmcid: 7029449
Craven J (2020, May 28) COVID-19 vaccine tracker. https://www.raps.org/news-and-articles/news-articles/2020/3/covid-19-vaccine-tracker
Darbeheshti F, Rezaei N (2020) Genetic predisposition models to COVID-19 infection. Med Hypotheses 142:109818
pubmed: 32416414 pmcid: 7202332
Diao B, Wang C, Tan Y, Chen X, Liu Y, Ning L, Chen L, Li M, Liu Y, Wang G (2020) Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19). Front Immunol 11:827
pubmed: 7205903 pmcid: 7205903
Doraiswamy S, Cheema S, Mamtani R (2020) Older people and epidemics: a call for empathy. Age Ageing 49(3):493–493
pubmed: 32227214 pmcid: 7184352
Dowell SF, Ho MS (2004) Seasonality of infectious diseases and severe acute respiratory syndrome-what we don’t know can hurt us. Lancet Infect Dis 4(11):704–708. https://doi.org/10.1016/S1473-3099(04)01177-6
doi: 10.1016/S1473-3099(04)01177-6 pubmed: 15522683 pmcid: 7129396
Dubey S, Biswas P, Ghosh R, Chatterjee S, Dubey MJ, Chatterjee S, Lahiri D, Lavie CJ (2020) Psychosocial impact of COVID-19. Diabetes Metab Syndr 14:779. https://doi.org/10.1016/j.dsx.2020.05.035
doi: 10.1016/j.dsx.2020.05.035 pubmed: 32526627 pmcid: 7255207
Fan EX (2003) SARS: economic impacts and implications. Asian Development Bank, Manila
Fathi N, Rezaei N (2020) Lymphopenia in COVID-19: therapeutic opportunities. Cell Biol Int 44:1792
pubmed: 32458561
Faye O, Faye O, Dupressoir A, Weidmann M, Ndiaye M, Sall AA (2008) One-step RT-PCR for detection of Zika virus. J Clin Virol 43(1):96–101
pubmed: 18674965
Fernandes N (2020) Economic effects of coronavirus outbreak (COVID-19) on the World Economy SSRN: https://ssrn.com/abstract=3557504 or https://doi.org/10.2139/ssrn.3557504
Fintelman-Rodrigues N, Sacramento CQ, Lima CR, da Silva FS, Ferreira A, Mattos M, de Freitas CS, Soares VC, Dias SD, Temerozo JR, Miranda M (2020, Jan 1) Atazanavir inhibits SARS-CoV-2 replication and pro-inflammatory cytokine production. bioRxiv
Gandhi M, Yokoe DS, Havlir DV (2020) Asymptomatic transmission, the Achilles’ heel of current strategies to control Covid-19. N Engl J Med 382(22):2158–2160. https://doi.org/10.1056/NEJMe2009758
doi: 10.1056/NEJMe2009758 pubmed: 32329972
Ghosh R, Dubey MJ, Chatterjee S, Dubey S (2020) Impact of COVID-19 on children: special focus on psychosocial aspect. Education 31:34
Goscé L, Phillips PA, Spinola P, Gupta DRK, Abubakar PI (2020) Modelling SARS-COV2 spread in London: approaches to lift the lockdown. J Infect 81:260. https://doi.org/10.1016/j.jinf.2020.05.037
doi: 10.1016/j.jinf.2020.05.037 pubmed: 32461062 pmcid: 7246004
Gralinski LE, Menachery VD (2020) Return of the coronavirus: 2019-nCoV. Viruses 12(2):135. https://doi.org/10.3390/v12020135
doi: 10.3390/v12020135 pmcid: 7077245
Gu J, Han B, Wang J (2020) COVID-19: gastrointestinal manifestations and potential fecal–oral transmission. Gastroenterology 158(6):1518–1519
pubmed: 32142785
Guan W-j, Liang W-h, Zhao Y, Liang H-r, Chen Z-s, Li Y-m, Liu X-q, Chen R-c, Tang C-l, Wang T, Ou C-q, Li L, Chen P-y, Sang L, Wang W, Li J-f, Li C-c, Ou L-m, Cheng B, Xiong S, Ni Z-y, Xiang J, Hu Y, Liu L, Shan H, Lei C-l, Peng Y-x, Wei L, Liu Y, Hu Y-h, Peng P, Wang J-m, Liu J-y, Chen Z, Li G, Zheng Z-j, Qiu S-q, Luo J, Ye C-j, Zhu S-y, Cheng L-l, Ye F, Li S-y, Zheng J-p, Zhang N-f, Zhong N-s, He J-x (2020a) Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J 55(5):2000547. https://doi.org/10.1183/13993003.00547-2020
doi: 10.1183/13993003.00547-2020 pubmed: 32217650 pmcid: 7098485
Guan W-j, Ni Z-y, Hu Y, Liang W-h, Ou C-q, He J-x, Liu L, Shan H, Lei C-l, Hui DSC, Du B, Li L-j, Zeng G, Yuen K-Y, Chen R-c, Tang C-l, Wang T, Chen P-y, Xiang J, Li S-y, Wang J-l, Liang Z-j, Peng Y-x, Wei L, Liu Y, Hu Y-h, Peng P, Wang J-m, Liu J-y, Chen Z, Li G, Zheng Z-j, Qiu S-q, Luo J, Ye C-j, Zhu S-y, Zhong N-s (2020b) Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 382(18):1708–1720. https://doi.org/10.1056/NEJMoa2002032
doi: 10.1056/NEJMoa2002032 pubmed: 32109013
Han R, Huang L, Jiang H, Dong J, Peng H, Zhang D (2020) Early clinical and CT manifestations of coronavirus disease 2019 (COVID-19) pneumonia. Am J Roentgenol 215:1–6. https://doi.org/10.2214/AJR.20.22961
doi: 10.2214/AJR.20.22961
Hanaei S, Rezaei N (2020) COVID-19: developing from an outbreak to a pandemic. Arch Med Res 51:582
pubmed: 32405122 pmcid: 7219390
Helmy YA, Fawzy M, Elaswad A, Sobieh A, Kenney SP, Shehata AA (2020) The COVID-19 pandemic: a comprehensive review of taxonomy, genetics, epidemiology, diagnosis, treatment, and control. J Clin Med 9(4):1225. https://doi.org/10.3390/jcm9041225
doi: 10.3390/jcm9041225 pmcid: 7230578
Henderson LA, Canna SW, Schulert GS, Volpi S, Lee PY, Kernan KF, Caricchio R, Mahmud S, Hazen MM, Halyabar O (2020) On the alert for cytokine storm: immunopathology in COVID-19. Arthritis Rheum 72:1059
Hessami A, Shamshirian A, Heydari K, Pourali F, Alizadeh-Navaei R, Moosazadeh M, Abrotan S, Shojaei L, Sedighi S, Shamshirian D, Rezaei N (2020, Oct 16) Cardiovascular diseases burden in COVID-19: Systematic review and meta-analysis. Am J Emerg Med
Hirbod-Mobarakeh A, Mahmoudi M, Rezaei N (2014) Nutrition, immunity, and aging. In: Immunology of aging. Springer, Berlin, pp 263–284
Hiscott J, Alexandridi M, Muscolini M, Tassone E, Palermo E, Soultsioti M, Zevini A (2020) The global impact of the coronavirus pandemic. Cytokine Growth Factor Rev 53:1. https://doi.org/10.1016/j.cytogfr.2020.05.010
doi: 10.1016/j.cytogfr.2020.05.010 pubmed: 32487439 pmcid: 7254014
Hu Y, Sun J, Dai Z, Deng H, Li X, Huang Q, Wu Y, Sun L, Xu Y (2020) Prevalence and severity of corona virus disease 2019 (COVID-19): a systematic review and meta-analysis. J Clin Virol 127:104371
pubmed: 32315817 pmcid: 7195434
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B (2020a) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet (London) 395(10223):497–506. https://doi.org/10.1016/s0140-6736(20)30183-5
doi: 10.1016/s0140-6736(20)30183-5
Huang X, Wei F, Hu L, Wen L, Chen K (2020b) Epidemiology and clinical characteristics of COVID-19. Arch Iran Med March 23(4):268–271. https://doi.org/10.34172/aim.2020.09
doi: 10.34172/aim.2020.09
Hung IF-N, Lung K-C, Tso EY-K, Liu R, Chung TW-H, Chu M-Y, Ng Y-Y, Lo J, Chan J, Tam AR, Shum H-P, Chan V, Wu AK-L, Sin K-M, Leung W-S, Law W-L, Lung DC, Sin S, Yeung P, Yip CC-Y, Zhang RR, Fung AY-F, Yan EY-W, Leung K-H, Ip JD, Chu AW-H, Chan W-M, Ng AC-K, Lee R, Fung K, Yeung A, Wu T-C, Chan JW-M, Yan W-W, Chan W-M, Chan JF-W, Lie AK-W, Tsang OT-Y, Cheng VC-C, Que T-L, Lau C-S, Chan K-H, To KK-W, Yuen K-Y (2020) Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial. Lancet 395(10238):1695–1704. https://doi.org/10.1016/S0140-6736(20)31042-4
doi: 10.1016/S0140-6736(20)31042-4 pubmed: 32401715 pmcid: 7211500
Jabbari P, Rezaei N (2020) With risk of reinfection, is COVID-19 here to stay? Disaster Med Public Health Prep:1. https://doi.org/10.1017/dmp.2020.274
Jabbari P, Jabbari F, Ebrahimi S, Rezaei N (2020, Jun) COVID-19: a chimera of two pandemics. Disaster Med Public Health Prep 14(3):e38–9
Jahanshahlu L, Rezaei N (2020a) Central nervous system involvement in COVID-19. Arch Med Res 51:721
pubmed: 32471704 pmcid: 7242947
Jahanshahlu L, Rezaei N (2020b) Monoclonal antibody as a potential anti-COVID-19. Biomed Pharmacother 129:110337
pubmed: 32534226 pmcid: 7269943
Jeong H, Yim HW, Song Y-J, Ki M, Min J-A, Cho J, Chae J-H (2016) Mental health status of people isolated due to middle east respiratory syndrome. Epidemiol Health 38:e2016048
pubmed: 28196409 pmcid: 5177805
Kim JY, Choe PG, Oh Y, Oh KJ, Kim J, Park SJ, Park JH, Na HK, Oh M-d (2020) The first case of 2019 novel coronavirus pneumonia imported into Korea from Wuhan, China: implication for infection prevention and control measures. J Korean Med Sci 35(5):e61
pubmed: 32030925 pmcid: 7008073
Lai J, Ma S, Wang Y, Cai Z, Hu J, Wei N, Wu J, Du H, Chen T, Li R (2020) Factors associated with mental health outcomes among health care workers exposed to coronavirus disease 2019. JAMA Netw Open 3(3):e203976–e203976
pubmed: 32202646 pmcid: 7090843
Lau JT, Tsui H, Lau M, Yang X (2004) SARS transmission, risk factors, and prevention in Hong Kong. Emerg Infect Dis 10(4):587
pubmed: 15200846 pmcid: 3323085
Leung K, Wu JT, Liu D, Leung GM (2020) First-wave COVID-19 transmissibility and severity in China outside Hubei after control measures, and second-wave scenario planning: a modelling impact assessment. Lancet 395(10233):1382–1393. https://doi.org/10.1016/S0140-6736(20)30746-7
doi: 10.1016/S0140-6736(20)30746-7 pubmed: 32277878 pmcid: 7195331
Li J-Y, You Z, Wang Q, Zhou Z-J, Qiu Y, Luo R, Ge X-Y (2020a) The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future. Microbes Infect 22(2):80–85. https://doi.org/10.1016/j.micinf.2020.02.002
doi: 10.1016/j.micinf.2020.02.002 pubmed: 32087334 pmcid: 7079563
Li X, Geng M, Peng Y, Meng L, Lu S (2020b) Molecular immune pathogenesis and diagnosis of COVID-19. J Pharm Anal 10(2):102–108. https://doi.org/10.1016/j.jpha.2020.03.001
doi: 10.1016/j.jpha.2020.03.001 pubmed: 32282863 pmcid: 7104082
Lipsitch M, Swerdlow DL, Finelli L (2020) Defining the epidemiology of Covid-19—studies needed. N Engl J Med 382(13):1194–1196
pubmed: 32074416
Liu P, Jiang J-Z, Wan X-F, Hua Y, Li L, Zhou J, Wang X, Hou F, Chen J, Zou J, Chen J (2020a) Are pangolins the intermediate host of the 2019 novel coronavirus (SARS-CoV-2)? PLoS Pathog 16(5):e1008421. https://doi.org/10.1371/journal.ppat.1008421
doi: 10.1371/journal.ppat.1008421 pubmed: 32407364 pmcid: 7224457
Liu Z, Xiao X, Wei X, Li J, Yang J, Tan H, Zhu J, Zhang Q, Wu J, Liu L (2020b) Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2. J Med Virol 92:595. https://doi.org/10.1002/jmv.25726
doi: 10.1002/jmv.25726 pubmed: 32100877
Lotfi M, Rezaei N (2020) SARS-CoV-2: a comprehensive review from pathogenicity of the virus to clinical consequences. J Med Virol 92:1864
pubmed: 32492197
Lotfi M, Hamblin MR, Rezaei N (2020) COVID-19: transmission, prevention, and potential therapeutic opportunities. Clin Chim Acta 508:254
pubmed: 32474009 pmcid: 7256510
Lovato A, de Filippis C (2020) Clinical presentation of COVID-19: a systematic review focusing on upper airway symptoms. Ear Nose Throat J 99:569.:0145561320920762. https://doi.org/10.1177/0145561320920762
doi: 10.1177/0145561320920762 pubmed: 32283980
Lu C-C, Chen M-Y, Chang Y-L (2020) Potential therapeutic agents against COVID-19: what we know so far. J Chin Med Assoc Latest Articles 83:534
Luan J, Lu Y, Jin X, Zhang L (2020) Spike protein recognition of mammalian ACE2 predicts the host range and an optimized ACE2 for SARS-CoV-2 infection. Biochem Biophys Res Commun 526(1):165–169. https://doi.org/10.1016/j.bbrc.2020.03.047
doi: 10.1016/j.bbrc.2020.03.047 pubmed: 32201080 pmcid: 7102515
Luo W, Yu H, Gou J, Li X, Sun Y, Li J, Liu L (2020) Clinical pathology of critical patient with novel coronavirus pneumonia (COVID-19). Preprints 2020:2020020407
Lurie N, Saville M, Hatchett R, Halton J (2020) Developing Covid-19 vaccines at pandemic speed. N Engl J Med 382(21):1969–1973. https://doi.org/10.1056/NEJMp2005630
doi: 10.1056/NEJMp2005630 pubmed: 32227757
Mahmoudi M, Rezaei N (2019) Nutrition and immunity. Springer, Cham
Mansourabadi AH, Sadeghalvad M, Mohammadi-Motlagh HR, Rezaei N (2020) The immune system as a target for therapy of SARS-CoV-2: a systematic review of the current immunotherapies for COVID-19. Life Sci 258:118185. https://doi.org/10.1016/j.lfs.2020.118185
doi: 10.1016/j.lfs.2020.118185 pubmed: 32750438 pmcid: 7395832
Masters PS (2006) The molecular biology of coronaviruses. Adv Virus Res 66:193–292
pubmed: 16877062 pmcid: 7112330
McKee M, Stuckler D (2020) If the world fails to protect the economy, COVID-19 will damage health not just now but also in the future. Nat Med 26(5):640–642. https://doi.org/10.1038/s41591-020-0863-y
doi: 10.1038/s41591-020-0863-y pubmed: 32273610
medicine USnlo (2020a) BCG vaccination to protect healthcare workers against COVID-19 (BRACE). https://clinicaltrials.gov/ct2/show/NCT04327206
medicine USnlo (2020b) Reducing health care workers absenteeism in Covid-19 pandemic through BCG vaccine (BCG-CORONA). https://clinicaltrials.gov/ct2/show/NCT04328441
Mehra MR, Desai SS, Ruschitzka F, Patel AN (2020) Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. Lancet. https://doi.org/10.1016/S0140-6736(20)31180-6
Miller AM (2020) How you should prepare for a potential ‘second wave’ of the coronavirus, according to experts. Business Insider France. https://www.businessinsider.fr/graphique-du-jour-titres-les-plus-ecoutes-sur-spotify-2017 . Accessed 25 May 2020
Mirbeyk M, Rezaei N (2020) The impact of COVID-19 on pregnancy and neonatal health: a systematic review
Moazzami B, Razavi-Khorasani N, Moghadam AD, Farokhi E, Rezaei N (2020) COVID-19 and telemedicine: immediate action required for maintaining healthcare providers Well-being. J Clin Virol 126:104345
pubmed: 32278298 pmcid: 7129277
Mohamed K, Rodríguez-Román E, Rahmani F, Zhang H, Ivanovska M, Makka SA, Joya M, Makuku R, Islam MS, Radwan N (2020a) Borderless collaboration is needed for COVID-19—a disease that knows no borders. Infect Control Hosp Epidemiol 41:1–2
Mohamed K, Yazdanpanah N, Saghazadeh A, Rezaei N (2020b) Computational drug discovery and repurposing for the treatment of COVID-19: a systematic review. Bioinorg Chem 104490. https://doi.org/10.1016/j.bioorg.2020.104490
Momtazmanesh S, Ochs HD, Uddin LQ, Perc M, Routes JM, Vieira DN, Al-Herz W, Baris S, Prando C, Rosivall L (2020) All together to fight COVID-19. Am J Trop Med Hyg 102(6):1181–1183
pubmed: 32323644 pmcid: 7253116
Monto AS, DeJonge PM, Callear AP, Bazzi LA, Capriola SB, Malosh RE, Martin ET, Petrie JG (2020) Coronavirus occurrence and transmission over 8 years in the HIVE cohort of households in Michigan. J Infect Dis 222:9. https://doi.org/10.1093/infdis/jiaa161
doi: 10.1093/infdis/jiaa161 pubmed: 32246136 pmcid: 7184402
Moradian N, Ochs HD, Sedikies C, Hamblin MR, Camargo CA, Martinez JA, Biamonte JD, Abdollahi M, Torres PJ, Nieto JJ (2020) The urgent need for integrated science to fight COVID-19 pandemic and beyond. J Transl Med 18(1):1–7
Nasab MG, Saghazadeh A, Rezaei N (2020) SARS-CoV-2-a tough opponent for the immune system. Arch Med Res 51:589. https://doi.org/10.1016/j.arcmed.2020.05.020
doi: 10.1016/j.arcmed.2020.05.020 pubmed: 32532524 pmcid: 7260490
Nicola M, Alsafi Z, Sohrabi C, Kerwan A, Al-Jabir A, Iosifidis C, Agha M, Agha R (2020) The socio-economic implications of the coronavirus and COVID-19 pandemic: a review. Int J Surg 78:185.:S1743-9191(1720)30316-30312. https://doi.org/10.1016/j.ijsu.2020.04.018
doi: 10.1016/j.ijsu.2020.04.018 pubmed: 32305533 pmcid: 7162753
Nishiura H, Kobayashi T, Miyama T, Suzuki A, Jung S-M, Hayashi K, Kinoshita R, Yang Y, Yuan B, Akhmetzhanov AR, Linton NM (2020) Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19). Int J Infect Dis 94:154–155. https://doi.org/10.1016/j.ijid.2020.03.020
doi: 10.1016/j.ijid.2020.03.020 pubmed: 32179137 pmcid: 7270890
Paraskevis D, Kostaki EG, Magiorkinis G, Panayiotakopoulos G, Sourvinos G, Tsiodras S (2020) Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event. Infect Genet Evol: J Mol Epidemiol Evol Genet Infect Dis 79:104212. https://doi.org/10.1016/j.meegid.2020.104212
doi: 10.1016/j.meegid.2020.104212
Park M, Cook AR, Lim JT, Sun Y, Dickens BL (2020) A systematic review of COVID-19 epidemiology based on current evidence. J Clin Med 9(4):967
pmcid: 7231098
Pashaei M, Rezaei N (2020) Immunotherapy for SARS-CoV-2: potential opportunities. Expert Opin Biol Ther 20:1–5. https://doi.org/10.1080/14712598.2020.1807933
doi: 10.1080/14712598.2020.1807933
Peeri NC, Shrestha N, Rahman MS, Zaki R, Tan Z, Bibi S, Baghbanzadeh M, Aghamohammadi N, Zhang W, Haque U (2020) The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? Int J Epidemiol 49:717
pubmed: 32086938
Peng X, Xu X, Li Y, Cheng L, Zhou X, Ren B (2020) Transmission routes of 2019-nCoV and controls in dental practice. Int J Oral Sci 12(1):1–6
Petrosillo N, Viceconte G, Ergonul O, Ippolito G, Petersen E (2020) COVID-19, SARS and MERS: are they closely related? Clin Microbiol Infect 26:729
pubmed: 32234451 pmcid: 7176926
Podile AR, Basu A (2020) Opportunities, challenges and directions in science and technology for tackling COVID-19. Trans Indian Natl Acad Eng 5:1–5. https://doi.org/10.1007/s41403-020-00111-z
doi: 10.1007/s41403-020-00111-z
Pourahmad R, Moazzami B, Rezaei N (2020) Efficacy of Plasmapheresis and Immunoglobulin Replacement Therapy (IVIG) on Patients with COVID-19. SN Compr Clin Med 2:1407–1411. https://doi.org/10.1007/s42399-020-00438-2
Prompetchara E, Ketloy C, Palaga T (2020) Immune responses in COVID-19 and potential vaccines: lessons learned from SARS and MERS epidemic. Asian Pac J Allergy Immunol 38(1):1–9
pubmed: 32105090
Rabiee N, Rabiee M, Bagherzadeh M, Rezaei N (2020) COVID-19 and picotechnology: potential opportunities. Med Hypotheses 144:109917
pubmed: 32505072 pmcid: 7263242
Rashid ZZ, Othman SN, Samat MNA, Ali UK, Wong KK (2020) Diagnostic performance of COVID-19 serology assays. Malays J Pathol 42(1):13–21
Rezaei N (2020a) COVID-19 affects healthy pediatricians more than pediatric patients. Infect Control Hosp Epidemiol 41:1. https://doi.org/10.1017/ice.2020.139
doi: 10.1017/ice.2020.139
Rezaei N (2020b) COVID-19 and medical biotechnology. Avicenna J Med Biotechnol 12(3):139
pubmed: 32695275 pmcid: 7368117
Richard Baldwin BWDM (2020, March 06) Economics in the time of COVID-19. A VoxEU.org Book, CEPR Press
Robertson E, Hershenfield K, Grace SL, Stewart DE (2004) The psychosocial effects of being quarantined following exposure to SARS: a qualitative study of Toronto health care workers. Can J Psychiatr 49(6):403–407
Rokni M, Hamblin MR, Rezaei N (2020) Cytokines and COVID-19: friends or foes? Hum Vaccin Immunother 16:1–3
Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C, Zimmer T, Thiel V, Janke C, Guggemos W (2020) Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med 382(10):970–971
pubmed: 32003551 pmcid: 7120970
Rubin GJ, Wessely S (2020) The psychological effects of quarantining a city. BMJ 368:m313
pubmed: 31992552
Rzymski P, Nowicki M, Mullin GE, Abraham A, Rodríguez-Román E, Petzold MB, Bendau A, Sahu KK, Ather A, Naviaux A-F (2020) Quantity does not equal quality: scientific principles cannot be sacrificed. Int Immunopharmacol 86:106711
pubmed: 32585609 pmcid: 7307981
Sabino-Silva R, Jardim ACG, Siqueira WL (2020) Coronavirus COVID-19 impacts to dentistry and potential salivary diagnosis. Clin Oral Investig 24(4):1619–1621
pubmed: 32078048
Saghazadeh A, Rezaei N (2017) Implications of toll-like receptors in Ebola infection. Expert Opin Ther Targets 21(4):415–425
pubmed: 28281905
Saghazadeh A, Rezaei N (2019) In: Rezaei N (ed) Introductory chapter: immunogenetics, immunogenetics. IntechOpen. https://doi.org/10.5772/intechopen.85505 . Available from: https://www.intechopen.com/books/immunogenetics/introductory-chapter-immunogenetics
Saghazadeh A, Rezaei N (2020a) Immune-epidemiological parameters of the novel coronavirus – a perspective. Expert Rev Clin Immunol 16(5):465–470. https://doi.org/10.1080/1744666x.2020.1750954
Saghazadeh A, Rezaei N (2020b) Towards treatment planning of COVID-19: rationale and hypothesis for the use of multiple immunosuppressive agents: anti-antibodies, immunoglobulins, and corticosteroids. Int Immunopharmacol 84:106560. https://doi.org/10.1016/j.intimp.2020.106560
doi: 10.1016/j.intimp.2020.106560 pubmed: 32413736 pmcid: 7205724
Sahu KK, Siddiqui AD, Rezaei N, Cerny J (2020) Challenges for management of immune thrombocytopenia during COVID-19 pandemic. J Med Virol 92:2277
pubmed: 32619062
Saleki K, Banazadeh M, Saghazadeh A, Rezaei N (2020) The involvement of the central nervous system in patients with COVID-19. Reviews in the Neurosciences 1, no. ahead-of-print
Sanchez E (2020) COVID-19 science: why testing is so important. American Heart Association. https://www.heart.org/en/news/2020/04/02/covid-19-science-why-testing-is-so-important . Accessed 25 May 2020
Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB (2020) Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review. JAMA 323(18):1824–1836. https://doi.org/10.1001/jama.2020.6019
doi: 10.1001/jama.2020.6019 pubmed: 32282022
Shamshirian D, Rezaei N (2020) Cardiovascular diseases burden in COVID-19: systematic review and meta-analysis
Sharifkashani S, Bafrani MA, Khaboushan AS, Pirzadeh M, Kheirandish A, Yavarpour Bali H, Hessami A, Saghazadeh A, Rezaei N (2020) Angiotensin-converting enzyme 2 (ACE2) receptor and SARS-CoV-2: potential therapeutic targeting. Eur J Pharmacol 884:173455. https://doi.org/10.1016/j.ejphar.2020.173455
doi: 10.1016/j.ejphar.2020.173455 pubmed: 32745604 pmcid: 7834210
Shereen MA, Khan S, Kazmi A, Bashir N, Siddique R (2020) COVID-19 infection: origin, transmission, and characteristics of human coronaviruses. J Adv Res 24:91–98. https://doi.org/10.1016/j.jare.2020.03.005
doi: 10.1016/j.jare.2020.03.005 pubmed: 32257431 pmcid: 7113610
Sim K, Chua HC (2004) The psychological impact of SARS: a matter of heart and mind. CMAJ 170(5):811–812
pubmed: 14993176 pmcid: 343855
Skowronski DM, Astell C, Brunham RC, Low DE, Petric M, Roper RL, Talbot PJ, Tam T, Babiuk L (2005) Severe acute respiratory syndrome (SARS): a year in review. Annu Rev Med 56:357–381
pubmed: 15660517
Song P, Karako T (2020) COVID-19: real-time dissemination of scientific information to fight a public health emergency of international concern. Biosci Trends 14:1
pubmed: 32092748
Spinato G, Fabbris C, Polesel J, Cazzador D, Borsetto D, Hopkins C, Boscolo-Rizzo P (2020) Alterations in smell or taste in mildly symptomatic outpatients with SARS-CoV-2 infection. JAMA 323(20):2089–2090. https://doi.org/10.1001/jama.2020.6771
doi: 10.1001/jama.2020.6771 pubmed: 32320008 pmcid: 7177631
Su S, Wong G, Shi W, Liu J, Lai ACK, Zhou J, Liu W, Bi Y, Gao GF (2016) Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends Microbiol 24(6):490–502. https://doi.org/10.1016/j.tim.2016.03.003
doi: 10.1016/j.tim.2016.03.003 pubmed: 27012512 pmcid: 7125511
Su H, Yang M, Wan C, Yi L-X, Tang F, Zhu H-Y, Yi F, Yang H-C, Fogo AB, Nie X, Zhang C (2020) Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int 98(1):219–227. https://doi.org/10.1016/j.kint.2020.04.003
doi: 10.1016/j.kint.2020.04.003 pubmed: 32327202 pmcid: 7194105
Sun LH (2020) CDC director warns second wave of coronavirus is likely to be even more devastating. The Washington Post. https://www.washingtonpost.com/health/2020/04/21/coronavirus-secondwave-cdcdirector/ . Accessed 25 May 2020
Thanh Le T, Andreadakis Z, Kumar A, Gomez Roman R, Tollefsen S, Saville M, Mayhew S (2020) The COVID-19 vaccine development landscape. Nat Rev Drug Discov 19(5):305–306. https://doi.org/10.1038/d41573-020-00073-5
doi: 10.1038/d41573-020-00073-5 pubmed: 32273591
Tian S, Xiong Y, Liu H, Niu L, Guo J, Liao M, Xiao S-Y (2020) Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies. Mod Pathol 33:1–8
Todd B (2020) Where are the masks? Am J Nurs 120(6):18–19. https://doi.org/10.1097/01.NAJ.0000668700.23009.1e
doi: 10.1097/01.NAJ.0000668700.23009.1e pubmed: 32443114
Verch T, Trausch JJ, Shank-Retzlaff M (2018) Principles of vaccine potency assays. Bioanalysis 10(3):163–180. https://doi.org/10.4155/bio-2017-0176
doi: 10.4155/bio-2017-0176 pubmed: 29333863
Verity R, Okell LC, Dorigatti I, Winskill P, Whittaker C, Imai N, Cuomo-Dannenburg G, Thompson H, Walker PGT, Fu H (2020) Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis 20:669
pubmed: 32240634 pmcid: 7158570
Wang M, Yan M, Xu H, Liang W, Kan B, Zheng B, Chen H, Zheng H, Xu Y, Zhang E (2005) SARS-CoV infection in a restaurant from palm civet. Emerg Infect Dis 11(12):1860
pubmed: 16485471 pmcid: 3367621
Wang Y, Zhang D, Du G, Du R, Zhao J, Jin Y, Fu S, Gao L, Cheng Z, Lu Q, Hu Y, Luo G, Wang K, Lu Y, Li H, Wang S, Ruan S, Yang C, Mei C, Wang Y, Ding D, Wu F, Tang X, Ye X, Ye Y, Liu B, Yang J, Yin W, Wang A, Fan G, Zhou F, Liu Z, Gu X, Xu J, Shang L, Zhang Y, Cao L, Guo T, Wan Y, Qin H, Jiang Y, Jaki T, Hayden FG, Horby PW, Cao B, Wang C (2020) Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet 395(10236):1569–1578. https://doi.org/10.1016/S0140-6736(20)31022-9
doi: 10.1016/S0140-6736(20)31022-9 pubmed: 32423584 pmcid: 7190303
Wang F, Kream RM, Stefano GB (2020a) An evidence based perspective on mRNA-SARS-CoV-2 vaccine development. Med Sci Monit 26:e924700. https://doi.org/10.12659/msm.924700
doi: 10.12659/msm.924700 pubmed: 32366816 pmcid: 7218962
Wang H-Y, Li X-L, Yan Z-R, Sun X-P, Han J, Zhang B-W (2020b) Potential neurological symptoms of COVID-19. Ther Adv Neurol Disord 13:1756286420917830. https://doi.org/10.1177/1756286420917830
doi: 10.1177/1756286420917830 pubmed: 32284735 pmcid: 7119227
Wang S, Wen X, Liu B, Dong Y, Cui M (2020c) Psychological influence of Coronovirus disease 2019 (COVID-19) pandemic on the general public, medical workers and patients with mental disorders and its countermeasures. Psychosomatics. https://doi.org/10.1016/j.psym.2020.05.005
Xiao K, Zhai J, Feng Y, Zhou N, Zhang X, Zou J-J, Li N, Guo Y, Li X, Shen X, Zhang Z, Shu F, Huang W, Li Y, Zhang Z, Chen R-A, Wu Y-J, Peng S-M, Huang M, Xie W-J, Cai Q-H, Hou F-H, Liu Y, Chen W, Xiao L, Shen Y (2020) Isolation and characterization of 2019-nCoV-like coronavirus from Malayan Pangolins. bioRxiv:2020.2002.2017.951335. https://doi.org/10.1101/2020.02.17.951335
Xie X, Zhong Z, Zhao W, Zheng C, Wang F, Liu J (2020a) Chest CT for typical 2019-nCoV pneumonia: relationship to negative RT-PCR testing. Radiology 296:E41. 200343
pubmed: 32049601
Xie Y, Cao S, Dong H, Li Q, Chen E, Zhang W, Yang L, Fu S, Wang R (2020b) Effect of regular intravenous immunoglobulin therapy on prognosis of severe pneumonia in patients with COVID-19. J Infect:S0163–4453(0120)30172–30179. https://doi.org/10.1016/j.jinf.2020.03.044
Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, Liu S, Zhao P, Liu H, Zhu L (2020) Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 8(4):420–422
pubmed: 32085846 pmcid: 7164771
Yan Y, Shin WI, Pang YX, Meng Y, Lai J, You C, Zhao H, Lester E, Wu T, Pang CH (2020) The first 75 days of novel coronavirus (SARS-CoV-2) outbreak: recent advances, prevention, and treatment. Int J Environ Res Public Health 17(7):2323. https://doi.org/10.3390/ijerph17072323
doi: 10.3390/ijerph17072323 pmcid: 7177691
Yang Y, Lu Q, Liu M, Wang Y, Zhang A, Jalali N, Dean N, Longini I, Halloran ME, Xu B, Zhang X (2020, Jan 1) Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China. MedRxiv
Yao H, Chen J-H, Xu Y-F (2020) Patients with mental health disorders in the COVID-19 epidemic. Lancet Psychiatry 7(4):e21
pubmed: 32199510 pmcid: 7269717
Yazdanpanah F, Hamblin MR, Rezaei N (2020a) The immune system and COVID-19: friend or foe? Life Sci 256:117900. https://doi.org/10.1016/j.lfs.2020.117900
doi: 10.1016/j.lfs.2020.117900 pubmed: 32502542 pmcid: 7266583
Yazdanpanah N, Saghazadeh A, Rezaei N (2020b) Anosmia: a missing link in the neuroimmunology of coronavirus disease 2019 (COVID-19). Rev Neurosci 31:691. https://doi.org/10.1515/revneuro-2020-0039
doi: 10.1515/revneuro-2020-0039 pubmed: 32776905
Ye Q, Wang B, Mao J (2020) The pathogenesis and treatment of theCytokine Storm’in COVID-19. J Infect 80(6):607–613
pubmed: 32283152 pmcid: 7194613
Yousefzadegan S, Rezaei N (2020) Case report: death due to COVID-19 in three brothers. Am J Trop Med Hyg 102(6):1203–1204
pubmed: 32277694 pmcid: 7253136
Yuan J, Hon C-C, Li Y, Wang D, Xu G, Zhang H, Zhou P, Poon LL, Lam TT-Y, Leung FC-C (2010) Intraspecies diversity of SARS-like coronaviruses in Rhinolophus sinicus and its implications for the origin of SARS coronaviruses in humans. J Gen Virol 91(4):1058–1062
pubmed: 20016037
Zheng M, Gao Y, Wang G, Song G, Liu S, Sun D, Xu Y, Tian Z (2020a) Functional exhaustion of antiviral lymphocytes in COVID-19 patients. Cell Mol Immunol 17(5):533–535
pubmed: 7091858 pmcid: 7091858
Zheng Y-Y, Ma Y-T, Zhang J-Y, Xie X (2020b) COVID-19 and the cardiovascular system. Nat Rev Cardiol 17(5):259–260
pubmed: 32139904
Zhong NS, Zeng GQ (2008) Pandemic planning in China: applying lessons from severe acute respiratory syndrome. Respirology 13:S33–S35. https://doi.org/10.1111/j.1440-1843.2008.01255.x
Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si HR, Zhu Y, Li B, Huang CL, Chen HD (2020a) Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin. bioRxiv. Cold Spring Harb Lab 2020:22–914952
Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si HR, Zhu Y, Li B, Huang CL, Chen HD, Chen J, Luo Y, Guo H, Jiang RD, Liu MQ, Chen Y, Shen XR, Wang X, Zheng XS, Zhao K, Chen QJ, Deng F, Liu LL, Yan B, Zhan FX, Wang YY, Xiao GF, Shi ZL (2020b) A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579(7798):270–273. https://doi.org/10.1038/s41586-020-2012-7
doi: 10.1038/s41586-020-2012-7 pubmed: 32015507 pmcid: 7095418

Auteurs

Nima Rezaei (N)

Universal Scientific Education and Research Network (USERN), Tehran, Iran. rezaei_nima@tums.ac.ir.
Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran. rezaei_nima@tums.ac.ir.

Saboura Ashkevarian (S)

Universal Scientific Education and Research Network (USERN), Tehran, Iran.
Research Institute of Applied Sciences, Academic Center of Education, Culture and Research (ACECR), Shahid Beheshti University, Tehran, Iran.

Mahsa Keshavarz Fathi (MK)

Universal Scientific Education and Research Network (USERN), Tehran, Iran.
Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.

Sara Hanaei (S)

Universal Scientific Education and Research Network (USERN), Tehran, Iran.
Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.

Zahra Kolahchi (Z)

Universal Scientific Education and Research Network (USERN), Tehran, Iran.
School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.

Seyedeh-Sanam Ladi Seyedian (SS)

Universal Scientific Education and Research Network (USERN), Tehran, Iran.
USC Institute of Urology, USC/Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.

Elham Rayzan (E)

Universal Scientific Education and Research Network (USERN), Tehran, Iran.
Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.

Mojdeh Sarzaeim (M)

Universal Scientific Education and Research Network (USERN), Tehran, Iran.
Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.

Aida Vahed (A)

Universal Scientific Education and Research Network (USERN), Tehran, Iran.

Kawthar Mohamed (K)

Universal Scientific Education and Research Network (USERN), Tehran, Iran.
School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.

Sarah Momtazmanesh (S)

Universal Scientific Education and Research Network (USERN), Tehran, Iran.
School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.

Negar Moradian (N)

Universal Scientific Education and Research Network (USERN), Tehran, Iran.
School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.

Zahra Rahimi Pirkoohi (ZR)

Universal Scientific Education and Research Network (USERN), Tehran, Iran.
Shahid Beheshti University, Tehran, Iran.

Noosha Sameeifar (N)

Universal Scientific Education and Research Network (USERN), Tehran, Iran.
School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Mahsa Yousefpour (M)

Universal Scientific Education and Research Network (USERN), Tehran, Iran.

Sepideh Sargoli (S)

Universal Scientific Education and Research Network (USERN), Tehran, Iran.

Saina Adiban (S)

Universal Scientific Education and Research Network (USERN), Tehran, Iran.

Aida Vahed (A)

Universal Scientific Education and Research Network (USERN), Tehran, Iran.

Niloufar Yazdanpanah (N)

Universal Scientific Education and Research Network (USERN), Tehran, Iran.
School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.

Heliya Ziaei (H)

Universal Scientific Education and Research Network (USERN), Tehran, Iran.
Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.

Amene Saghazadeh (A)

Universal Scientific Education and Research Network (USERN), Tehran, Iran.
Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Maladies de l'appareil respiratoire › Infections de l'appareil respiratoire › Pneumopathie infectieuse › Pneumopathie virale › COVID-19 › Introduction on Coronavirus Disease (COVID-19)...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Introduction on Coronavirus Disease (COVID-19)...
questionsmedicales.fr › Professions de santé › Médecine › Introduction on Coronavirus Disease (COVID-19)...
questionsmedicales.fr › Virus › Virus à ARN › Virus à ARN à brin positif › Nidovirales › Coronaviridae › Coronavirus › Betacoronavirus › Coronavirus du syndrome respiratoire du Moyen-Orient › Introduction on Coronavirus Disease (COVID-19)...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Épidémies de maladies › Épidémies › Pandémies › Introduction on Coronavirus Disease (COVID-19)...
questionsmedicales.fr › Virus › Virus à ARN › Virus à ARN à brin positif › Nidovirales › Coronaviridae › Coronavirus › Betacoronavirus › Virus du SRAS › SARS-CoV-2 › Introduction on Coronavirus Disease (COVID-19)...